$NUS

1 thesis
bullish 100%neutral 0%bearish 0%
Avg return (1w)
—
Win rate (1w)
— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$NUSr/wallstreetbetsDDbullish
u/jsimpy · 19h agono track record yet
“11,500 shares across three brokerages”

$NUS is way undervalued, zero net debt, and an unfilled gap to $9.78 that’s still below tangible book

Nu Skin trades at 0.47x tangible book value with net working capital ($5.19/share) exceeding stock price ($4.82), essentially zero net debt, and an unfilled daily gap to $9.78 that represents +103% upside while still 5% below tangible book. Despite structural revenue decline and balance sheet deterioration risks, the combination of deep asset discount, high dividend yield (5%), and chart gap support presents significant asymmetric upside.

At post $4.87live price unavailable
original post →

End of results.